
Article 1 

1. The health claims listed in Annex I to this Regulation may be made on foods on the  Great Britain  market in compliance with the conditions laid down in that Annex.
2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 2 
The health claim listed in Annex II to this Regulation  may not be made on foods on the  Great Britain  market.
Article 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...Done at Brussels, 11 July 2011.
For the Commission
The President
José Manuel BARROSO
ANNEX I
Application – Relevant provisions of Regulation (EC) No 1924/2006 Applicant – Address Nutrient, substance, food or food category Claim Conditions of use of the claim Conditions and/or restrictions of use of the food and/or additional statement or warning EFSA opinion reference
Article 14(1)(a) health claim referring to reduction of disease risk Wrigley GmbH, Scientific and Regulatory Affairs EMEAI, Biberger Str. 18, 82008 Unterhaching, GERMANY Sugar-free chewing gum Sugar-free chewing gum helps reduce tooth demineralisation. Tooth demineralisation is a risk factor in the development of dental caries. Information shall be given to the consumer that the beneficial effect is obtained with chewing of 2-3 g of sugar-free chewing gum for 20 minutes, at least three times per day after meals.  Q-2010-00119
Article 14(1)(a) health claim referring to reduction of disease risk Wrigley GmbH, Scientific and Regulatory Affairs EMEAI, Biberger Str. 18, 82008 Unterhaching, GERMANY Sugar-free chewing gum Sugar-free chewing gum helps neutralise plaque acids. Plaque acids are a risk factor in the development of dental caries. Information shall be given to the consumer that the beneficial effect is obtained with chewing of 2-3 g of sugar-free chewing gum for 20 minutes, at least three times per day after meals.  Q-2010-00120
ANNEX II
Application – Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease risk OPC Plus OPC Plus has been shown to increase the microcirculation and may therefore reduce the risk of chronic venous insufficiency Q-2009-00751